Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | MDGL | GRFS | ||
| Company | Cerevel Therapeutics Hldg Inc | Madrigal Pharmaceuticals Inc | Grifols S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.99 | 477.60 | 9.35 | ||
| High | 44.99 | 489.56 | 9.35 | ||
| Low | 44.96 | 471.39 | 9.23 | ||
| Latest | 44.96 | 489.21 | 9.32 | ||
| Change | +0.33 | +11.61 | +0.04 | ||
| % Change | +0.74% | +2.43% | +0.43% | ||
| Volume | 15,096,300 | 89,635 | 75,965 | ||
| 20-Day Average Volume | 2,839,210 | 309,896 | 455,316 | ||
| Previous Close | 44.63 | 477.60 | 9.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 492.04 | 9.17 | ||
| 20-Day Raw Stochastic | 99.49% | 38.79% | 72.68% | ||
| 20-Day Relative Strength | 68.05 | 40.68 | 53.15 | ||
| Weighted Alpha | +49.03 | +43.29 | +22.23 | ||
| Today's Opinion | 72% Buy | 8% Buy | 16% Buy | ||
| Previous Opinion | 72% Buy | 8% Buy | 24% Buy | ||
| Last Month's Opinion | 8% Buy | 80% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | -1.75% since 02/02/26 | -0.69% since 02/02/26 | ||
| Low | 43.75 on 07/25/24 | 458.00 on 02/05/26 | 9.09 on 02/06/26 | ||
| High | 44.99 on 07/31/24 | 491.29 on 02/03/26 | 9.60 on 02/04/26 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | -6.40% since 01/09/26 | -0.37% since 01/09/26 | ||
| Low | 39.16 on 07/03/24 | 458.00 on 02/05/26 | 8.63 on 01/20/26 | ||
| High | 44.99 on 07/31/24 | 517.71 on 01/12/26 | 9.60 on 02/04/26 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | -1.66% since 11/07/25 | +10.60% since 11/07/25 | ||
| Low | 38.50 on 06/25/24 | 458.00 on 02/05/26 | 7.64 on 12/02/25 | ||
| High | 44.99 on 07/31/24 | 615.00 on 12/24/25 | 9.60 on 02/04/26 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +39.17% since 08/08/25 | -12.43% since 08/08/25 | ||
| Low | 38.50 on 06/25/24 | 342.73 on 08/11/25 | 7.64 on 12/02/25 | ||
| High | 44.99 on 07/31/24 | 615.00 on 12/24/25 | 10.84 on 08/14/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 10,846,774 | 6,380,557 | ||
| Shares Outstanding, K | 182,195 | 22,711 | 687,560 | ||
| Annual Sales | 0 | 180,130,000 | 7,804,520,000 | ||
| Annual Net Income | -432,840,000 | -465,890,000 | 169,800,000 | ||
| Last Quarter Sales | 0 | 287,270,000 | 2,180,470,000 | ||
| Last Quarter Net Income | -131,910,000 | -114,190,000 | 148,410,000 | ||
| 60-Month Beta | 1.40 | -1.01 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -5.08 on 11/04/25 | 0.19 on 07/28/25 | ||
| Latest Earnings Date | 08/07/24 | 02/19/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | 0.142 on 08/12/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 08/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||